9,10-dimethyl-1,2-benzanthracene and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one

9,10-dimethyl-1,2-benzanthracene has been researched along with 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benakanakere, I; Besch-Williford, C; Ellersieck, MR; Hyder, SM	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one

Article	Year
Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study. Endocrine-related cancer, 2009, Volume: 16, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carcinogens; Drug Resistance, Neoplasm; Female; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mutation; Neovascularization, Pathologic; Osteonectin; Pilot Projects; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A	2009

Article

Year

Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.

Endocrine-related cancer, 2009, Volume: 16, Issue:1

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carcinogens; Drug Resistance, Neoplasm; Female; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mutation; Neovascularization, Pathologic; Osteonectin; Pilot Projects; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

2009